After acquiring 60% stake in a Sri Lanka-based company, this is the second buyout of Cipla this mon…

Donald Trump's State of the Union address had a warning sign for Indian pharmaceutical companies. W…

A lot of people in the industry announced new roles this week. Merck's Adam Schechter is slated to …

Cipla is all set to expand its portfolio. And this includes buying of the American business of Hyde…

Allergan plc today confirmed that it has been approached by Pfizer Inc. and is in preliminary frien…

Aurobindo Pharma Ltd., a mid-sized drugs major, was the second best gainer in the pharma sector on …

Sources said that the process of merging ONGC's two oil refining subsidiaries, HPCL and MRPL, wi…

The lawsuit is the second to be brought as part of an investigation by the states into generic drug…

The latest complaint has a similar focus on generic drugs and names a similar group of generic drug…

Welcome to Dispensed Daily, your daily dose of healthcare news. Inside: Why generic drugmaker Perri…

Pharmaceuticals in India have produced the highest number of billionaires numbering 137. The r…

The size and diversity of the healthcare sector make it a key industry for investors building a div…

As the death toll in the country from coronavirus jumped by a record 445 to 13,699, the Centre mai…

Glenmark Pharmaceuticals has launched the antiviral drug Favipiravir, under the brand name FabiFlu…

Amidst mixed cues from the global markets, the Indian equities are likely to open flat on Tuesday. …

The stand-alone total income from operations of the company declined 4.4% to Rs 224.43 crore during…

The drugmaker reports its earnings on October 24 and Goldman says it faces major challenges. Vivek …

"Given that it was charging a lower price for Inflectra than J&J was charging for Remicade, Pfi…

You might think of Walmart as a giant retail business, but the company is also one of the largest p…

"Under this proposal, a pharmacy could meet most of the CMS benchmarks, provide quality customer ca…